Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty
War Wounded
Investigator Initiated Trial- Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty. Comparison of Spinal Cord Stimulation and Comprehensive Medical Management
1 other identifier
interventional
180
1 country
1
Brief Summary
The purpose of this study is to determine the degree to which spinal cord stimulation added to comprehensive medical management can provide increased relief of chronic pain in patients with injuries sustained while on active military duty, measured by patient assessments of pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Dec 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedFirst Posted
Study publicly available on registry
June 11, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedJune 11, 2012
June 1, 2012
2 years
October 26, 2011
June 7, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Change in pain score
Change from Baseline to Week 24 in weekly mean of average daily pain scores at the target site of pain (target pain, TP), based on an 11-point Numerical Pain Rating Scale (NPRS), by treatment group.
144 weeks
Secondary Outcomes (22)
change in related pain
144 weeks
change in mean daily pain score
144 weeks
change in mean pain per treatment group
144 weeks
change in MPQ per treatment group
144 weeks
change in spine related pain
144 weeks
- +17 more secondary outcomes
Study Arms (2)
Comprehensive Medical Management
ACTIVE COMPARATORComprehensive Medical Management will include analgesic management in accordance with guidelines and practices at the site.
Spinal Cord Stimulation (SCS)
ACTIVE COMPARATORSubjects assigned to Arm A, CMM + SCS, will be treated with electrical pulses from a surgically implanted Precision Plus® SCS System (Boston Scientific Corporation).
Interventions
Precise (TM) spinal cord stimulator from boston scientific, and comprehensive mdedical management.
Eligibility Criteria
You may qualify if:
- Subject is a veteran or active duty service member injured while on active military duty receiving care for pain related to the injury(ies) in the Department of Defense health care system or through the Department of Veteran's Affairs.
- Subject is 18 years of age or older.
- The elapsed time since the active-duty injury leading to chronic pain is not less than 3 months.
- Subject reports constant or daily episodes of injury-related pain of at least moderate severity, graded 4 or higher on an 11-point NPRS (point estimate by subject and Investigator at time of enrolment based on overall pain or pain at a specific site). Pain may be nociceptive, neuropathic, or mixed. Phantom pain associated with amputation of an extremity or extremities is allowed.
- Attempts to control pain with commercially available systemic analgesics have not provided adequate relief, in the judgment of the managing physician and subject.
- Subject is an acceptable candidate for surgical placement of an indwelling spinal cord stimulation device.
- Subject is judged an appropriate candidate for treatment using the available techniques and interventions encompassed within the protocol's definition of comprehensive medical management.
- For the duration of the trial, subject is willing to limit interventions for control of chronic pain to those approved by the Investigator.
- The subject is judged psychologically appropriate for either treatment intervention, based on the impression of an interviewing psychologist or psychiatrist.
- Subject provides informed consent.
You may not qualify if:
- Subject experiences phantom pain associated with amputation of both an upper and lower extremity.
- Subject has headache or visceral truncal pain or other non-musculoskeletal pain as the only pain that results in constant or daily scores of ≥4 on the 11-point NPRS.
- Subject has spinal disease that would, in the judgment of the investigator, - Subject has ongoing chronic infection or a medical condition associated with an unacceptably increased risk of infection related to device implantation.
- Subject has a current diagnosis or history of psychosis, cognitive impairment, hallucinations, or unexplained loss of consciousness, whether or not related to a combat injury that, in the opinion of the investigator, would exclude the patient from participating in the trial.
- Subject has a cardiac pacemaker.
- Subject has any significant medical or psychiatric condition that would interfere with the conduct of the study or with the outcome measures.
- Subject is pregnant or is breast feeding.
- Subject has participated in any drug or device trial in the past 30 days.
- Subject has any planned elective or semi-elective surgery during the 6 months of the Primary Treatment Phase, including stump revisions or grafting.
- Subject has a psychological condition of great enough severity that it would unacceptably increase the medical risks associated with implantation and care of the devices required for the treatment on the CMM + SCS arm, or would likely interfere with the subject's ability to sustain participation in a research study of long duration. Investigators are encouraged to include the medical monitor and the coordinating investigator in discussions about individual candidate subjects who have psychological diagnoses as part of the polytrauma syndrome before enrollment or treatment on this protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sceptor Pain Foundationlead
- Boston Scientific Corporationcollaborator
Study Sites (1)
Center for Clinical Research
Winston-Salem, North Carolina, 27103, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Rauck, MD
The Center for Clinical Research
- STUDY CHAIR
Derry Ridgeway, MD
SRA International
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2011
First Posted
June 11, 2012
Study Start
December 1, 2011
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
June 11, 2012
Record last verified: 2012-06